PLURI BIOTECH LTD – Trademark Portfolio
Entity Type: 99
PLURI BIOTECH LTD holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include PLURI and COFFEESAI.
Matam 20
31905 Haifa
Showing of trademarks Trademarks
Trademark Classifications
PLURI BIOTECH LTD's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does PLURI BIOTECH LTD have?
PLURI BIOTECH LTD has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does PLURI BIOTECH LTD file in?
PLURI BIOTECH LTD files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are PLURI BIOTECH LTD's most well-known trademarks?
PLURI BIOTECH LTD's registered trademark portfolio includes well-known marks such as PLURI and COFFEESAI. These are among 3 currently registered trademarks in the portfolio.
What is PLURI BIOTECH LTD's trademark registration success rate?
PLURI BIOTECH LTD has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.